Notice of Retraction: Acharya P, Engel JC, Correia MA (2009) Hepatic CYP3A suppression by high concentrations of proteasomal inhibitors: A consequence of endoplasmic reticulum (ER) stress induction, activation of RNA-dependent protein kinase-like ER-bound eukaryotic initiation factor 2 α (eIF2 α)-kinase (PERK) and general control nonderepressible-2 eIF2 α kinase (GCN2), and global translational shutoff. Mol Pharmacol 76(3):503-515; DOI: https://doi.org/10.1124/mol.109.056002
- PMID: 34404737
- PMCID: PMC8382260
- DOI: 10.1124/mol.109.056002retraction
Notice of Retraction: Acharya P, Engel JC, Correia MA (2009) Hepatic CYP3A suppression by high concentrations of proteasomal inhibitors: A consequence of endoplasmic reticulum (ER) stress induction, activation of RNA-dependent protein kinase-like ER-bound eukaryotic initiation factor 2 α (eIF2 α)-kinase (PERK) and general control nonderepressible-2 eIF2 α kinase (GCN2), and global translational shutoff. Mol Pharmacol 76(3):503-515; DOI: https://doi.org/10.1124/mol.109.056002
Retraction of
-
Hepatic CYP3A suppression by high concentrations of proteasomal inhibitors: a consequence of endoplasmic reticulum (ER) stress induction, activation of RNA-dependent protein kinase-like ER-bound eukaryotic initiation factor 2alpha (eIF2alpha)-kinase (PERK) and general control nonderepressible-2 eIF2alpha kinase (GCN2), and global translational shutoff.Mol Pharmacol. 2009 Sep;76(3):503-15. doi: 10.1124/mol.109.056002. Epub 2009 Jun 11. Mol Pharmacol. 2009. Retraction in: Mol Pharmacol. 2021 Aug;100(2):82. doi: 10.1124/mol.109.056002retraction. PMID: 19520899 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources
